Monday March 22 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
BioNews - BioPortfolio's News Portal
San Francisco Chronicle Biotechnology and Pharmaceutical News and Headlines
Sign-up to BioPortfolio's
San Francisco Chronicle Biotechnology and Pharmaceutical news alerts
.
Subscribe to
BioWatch News Email alerts
-
open
BioWatch PDF brochure
.
Publish your news
using BioNewsCast
- open
BioNewsCast PDF brochure
.
Scientists + Artists = "Incredible Debates" and "Medium Fun"
San Francisco Chronicle:
similar ...
Asians differ when it comes to rates of disease
San Francisco Chronicle:
similar ...
FDA Denies Approval For A. P. Pharma's Nausea Treatment
San Francisco Chronicle:
similar ...
Lilly asks public to watch for stolen Conn. drugs
San Francisco Chronicle:
similar ...
AstraZeneca wins 1st trial over alleged drug harm
San Francisco Chronicle:
similar ...
Teva to buy German generic drug maker Ratiopharm
San Francisco Chronicle:
similar ...
Teva and Merck agree on generic Temodar launch
San Francisco Chronicle:
similar ...
J&J CEO Weldon gets 11 pct 2009 raise, to $25.6M
San Francisco Chronicle:
similar ...
Clarification: Amylin FDA info request story
San Francisco Chronicle:
similar ...
Sequenom Widens Losses
San Francisco Chronicle:
similar ...
$70M in prescription drugs stolen in Conn. heist
San Francisco Chronicle:
similar ...
Study: Gene testing helps get warfarin dose right
San Francisco Chronicle:
similar ...
Giants Tailgate Benefiting Dan Darcy's Band Against Cancer
San Francisco Chronicle:
similar ...
IMS: China to be 3rd largest pharma market in 2011
San Francisco Chronicle:
similar ...
Abbott CEO's pay falls on reduced stock options
San Francisco Chronicle:
similar ...
Pfizer: More Lipitor cuts heart complications more
San Francisco Chronicle:
similar ...
No New Studies Needed From Amylin, Eli Lilly and Alkermes
San Francisco Chronicle:
similar ...
No New Studies Needed From Amylin, Eli Lilly and Alkermes
San Francisco Chronicle:
similar ...
Amylin shares up on FDA response for diabetes drug
San Francisco Chronicle:
similar ...
BioSante cancer vaccine gets 'orphan drug' status
San Francisco Chronicle:
similar ...
